Welcome to our blog on precision oncology, "Cancer is Personal", a space dedicated to exploring how personalized, data-driven cancer treatments are transforming cancer care, improving outcomes, and minimizing side effects.

Search by Resource Topic:
Sort by Date Posted:
Search by Keywords:

Gene Expression Panels: Listening to What Your Tumor Is Doing

Introduction When most people think about cancer testing, they think about looking for something specific. A mutation, a protein, a genetic change. The tests we explored in our previous articles largely work this way: they scan a tumor for a known target and tell you whether it is there or not. But what if the […]

Kira Grewal, MSc
May 27, 2026

4 min read

Predictive Biomarkers: Matching the Right Treatment to the Right Patient

Introduction In our previous article, we explored the different categories of biomarkers used in cancer care, from those that signal disease risk to those that help monitor a patient’s response over time. Among these categories, one stands out as particularly central to the promise of precision oncology: the predictive biomarker. While prognostic biomarkers tell us […]

Kira Grewal, MSc
April 30, 2026

7 min read

From Lab to Clinic: The Diagnostic Tests Putting Precision Oncology into Practice

Introduction In our previous article, we explored the different types of biomarkers and why they matter in cancer care. Biomarkers can signal disease risk, confirm a diagnosis, predict how a cancer will behave, and guide treatment decisions. But knowing that these biomarkers exist is only part of the story. The next question is how these […]

Kira Grewal, MSc
April 16, 2026

5 min read

Understanding Biomarkers: The Foundation of Precision Oncology

Introduction In our previous blog post, we explored some of the early breakthroughs that reshaped cancer treatment. Precision oncology is an approach to cancer treatment that is tailored to the unique biology of a patient’s tumor. This raises an important question: what makes precision oncology possible? The answer lies in biological markers, more commonly known […]

Kira Grewal, MSc
April 2, 2026

4 min read

Notable Early Successes in Precision Oncology: The Breakthroughs That Redefined Cancer Treatment

Introduction Precision oncology began gaining traction in the late 1990s and has since reshaped how we understand and treat cancer. Rather than classifying tumors solely by where they arise in the body, precision oncology asks a more fundamental question: What molecular alteration is driving this cancer? Our previous blog post, Precision Oncology Explained, explored what […]

Kira Grewal, MSc
March 3, 2026

5 min read

Prognostic Biomarkers for Papillary Thyroid Cancer: Reducing Overtreatment, Improving Clinical Efficiency, and Enhancing Patient Experience

Abstract Papillary thyroid cancer (PTC), the most prevalent form of thyroid malignancy, is generally indolent but poses a recurrence risk of 10%-15%, leading to a clinical paradox: the need to mitigate recurrence while avoiding overtreatment. Current prognostic frameworks, reliant on anatomical and histopathological factors, often result in inefficient treatment pathways, unnecessary surgical interventions, and increased […]

Qualisure Diagnostics Inc.
November 11, 2025

1 min read
No more posts to show